ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1888

Reliability, Validity, and Sensitivity to Change of the Simplified Duruoz Hand Index in Systemic Sclerosis

Ana Maria Gheorghiu1, Hermina Gyorfi1, Razvan Capota1, Alexandru Matei1, Raida Oneata1, Liviu Macovei1, Mihaela Milicescu1, Mariana Sasu1, Mihai Bojinca2, Victor Stoica1 and Carina Mihai1, 1Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology Department, Cantacuzino Clinical Hospital, Bucharest, Romania, 2Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology Department, Cantacuzino Clinical Hospital, Bucuresti, Romania

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Hand involvement is observed in almost all patients with Systemic Sclerosis (SSc), and is due in various proportions to skin and tendon fibrosis, arthritis and microvascular impairment, sometimes complicated with digital ulcers (DUs). The Duruoz’s Hand Index (DHI) (or Cochin hand functional disability scale), is a reliable tool for hand function assessment in diseases like rheumatoid arthritis and SSc. A short form of the DHI comprising of 6 items (DHI-6) has been recently developed and validated. The purpose of this study was to assess the reliability, validity and sensitivity to change of the new DHI-6 in a cohort of patients with SSc.

Methods: 70 consecutive patients with SSc, examined in our EUSTAR center, satisfying the 2013 ACR/EULAR classification criteria, were included. Patients completed the DHI, the Scleroderma Health Assessment Questionnaire (SHAQ) questionnaires and the Hand Mobility in Scleroderma (HAMIS) test. Three anthropometric measures to assess finger range of motion were also measured: the finger extension (FE), finger-to-palm distance (FTP) and Δ FTP (FE – FTP). Step 1: In 38 patients the test-retest reliability, using intra-class correlation coefficients (ICC), and the internal consistency (Cronbach’s alpha test) were examined. Step 2: In all 70 patients, the criterion validity by correlation coefficients with SHAQ, HAMIS and the anthropometric measures, and the discriminative capacity between different subsets of patients by Mann-Whitney U-test were examined. Moreover, the DHI-6 was correlated with DHI. Step 3: 35 consecutive patients had a second evaluation at an interval of (mean± SD) 8.1±30. months; among them, 8 patients had progressive early diffuse SSc. Sensitivity to change was assessed in these patients using the effect size (ES) (Cohen’s d) and the standardized response mean (SRM).

Results: The study included 63 females/7 males with SSc, age 50.9±13.0 years, disease duration 5.8±5.6 years; 27 with diffuse cutaneous SSc (dcSSc) and 43 with limited cutaneous SSc (lcSSc). The DHI-6 had a score of 6.7±6.5, range 0-25 (possible range 0-30) at baseline, and 8.3±7.0, range 0-24 at follow-up. The DHI-6 presented an excellent test-retest reliability (ICC 0.98), and a good internal consistency (Cronbach’s alpha 0.89). Criterion validity of the DHI-6 was proved by moderate to strong correlations with HAMIS, FE, FTP, Δ FTP and the SHAQ disability index (Spearman’s rho 0.48-0.82, p<001). Correlation of the DHI-6 with the DHI was excellent, with a Spearman’s rho of 0.96, p<0.001. The discriminative capacity of the DHI-6 was proven by statistically significant differences between patients with and without: synovitis, flexion contractures of the fingers, and history of DUs. The sensitivity to change (ES of 0.57 and SRM of 1.11) was very good for detecting a minimally important difference.

Conclusion: The simplified DHI is a brief, valid and reliable instrument for measuring hand disability in SSc. These results suggest that the DHI-6 could be used both in day-to-day practice and in clinical trials, reducing patient burden and increasing research capacity. However, more studies are needed to confirm these results.


Disclosure: A. M. Gheorghiu, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; H. Gyorfi, None; R. Capota, None; A. Matei, None; R. Oneata, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; L. Macovei, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; M. Milicescu, None; M. Sasu, None; M. Bojinca, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; V. Stoica, None; C. Mihai, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2.

To cite this abstract in AMA style:

Gheorghiu AM, Gyorfi H, Capota R, Matei A, Oneata R, Macovei L, Milicescu M, Sasu M, Bojinca M, Stoica V, Mihai C. Reliability, Validity, and Sensitivity to Change of the Simplified Duruoz Hand Index in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/reliability-validity-and-sensitivity-to-change-of-the-simplified-duruoz-hand-index-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reliability-validity-and-sensitivity-to-change-of-the-simplified-duruoz-hand-index-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology